|
1
|
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.
|
Ann Rheum Dis
|
2005
|
2.08
|
|
2
|
Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
|
J Rheumatol
|
2001
|
1.76
|
|
3
|
Gender differences in the incidence and prevalence of patellofemoral pain syndrome.
|
Scand J Med Sci Sports
|
2010
|
1.65
|
|
4
|
Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome.
|
Arthritis Rheum
|
1995
|
1.43
|
|
5
|
The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year.
|
Ann Rheum Dis
|
2006
|
1.24
|
|
6
|
Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2.
|
Arthritis Rheum
|
2007
|
1.21
|
|
7
|
Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis.
|
Ann Rheum Dis
|
2005
|
1.05
|
|
8
|
Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial.
|
Ann Rheum Dis
|
2006
|
1.05
|
|
9
|
Osteoarticular infections due to Kingella kingae in children.
|
Eur J Pediatr
|
1991
|
0.87
|
|
10
|
Finger pad tophi in gout.
|
J Rheumatol
|
1996
|
0.78
|
|
11
|
Morphometric studies on synovium in advanced osteoarthritis: is there an association between apatite-like material and collagen deposits?
|
Clin Exp Rheumatol
|
1997
|
0.77
|
|
12
|
[Acute poisoning with a narcotic (Tramadol) in an infant of five weeks].
|
Helv Paediatr Acta
|
1988
|
0.75
|
|
13
|
The effect of dopamine on blood flow in skeletal muscles.
|
Pol J Pharmacol Pharm
|
1989
|
0.75
|
|
14
|
The role of sympathetic nervous system in the action of dopamine and dobutamine on the function of circulatory system.
|
Pol J Pharmacol Pharm
|
1990
|
0.75
|